High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/ refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - A CALGB 59804 correlative study

Raymond Lai; Nancy L. Bartlett; John R. Mackey; Sin Ho Jung; Jeffrey L. Johnson; James R. Cook; Dan Jones; Carol E. Cass; James D. Young; Jonathan Said; Bruce Cheson; Eric D. Hsi

doi:10.1080/10428190802094237

High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/ refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - A CALGB 59804 correlative study

Raymond Lai, Nancy L. Bartlett, John R. Mackey, Sin Ho Jung, Jeffrey L. Johnson, James R. Cook, Dan Jones, Carol E. Cass, James D. Young, Jonathan Said, Bruce Cheson, Eric D. Hsi

Research output: Contribution to journal › Letter › peer-review

10 Scopus citations

Original language	English
Pages (from-to)	1202-1205
Number of pages	4
Journal	Leukemia and Lymphoma
Volume	49
Issue number	6
DOIs	https://doi.org/10.1080/10428190802094237
State	Published - Jun 2008

Access to Document

10.1080/10428190802094237

Cite this

Lai, R., Bartlett, N. L., Mackey, J. R., Jung, S. H., Johnson, J. L., Cook, J. R., Jones, D., Cass, C. E., Young, J. D., Said, J., Cheson, B., & Hsi, E. D. (2008). High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/ refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - A CALGB 59804 correlative study. Leukemia and Lymphoma, 49(6), 1202-1205. https://doi.org/10.1080/10428190802094237

Lai, Raymond ; Bartlett, Nancy L. ; Mackey, John R. et al. / High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/ refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - A CALGB 59804 correlative study. In: Leukemia and Lymphoma. 2008 ; Vol. 49, No. 6. pp. 1202-1205.

@article{aac7a458330247a29d0e2cdfa118f830,

title = "High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/ refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - A CALGB 59804 correlative study",

author = "Raymond Lai and Bartlett, {Nancy L.} and Mackey, {John R.} and Jung, {Sin Ho} and Johnson, {Jeffrey L.} and Cook, {James R.} and Dan Jones and Cass, {Carol E.} and Young, {James D.} and Jonathan Said and Bruce Cheson and Hsi, {Eric D.}",

year = "2008",

month = jun,

doi = "10.1080/10428190802094237",

language = "English",

volume = "49",

pages = "1202--1205",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

number = "6",

}

Lai, R, Bartlett, NL, Mackey, JR, Jung, SH, Johnson, JL, Cook, JR, Jones, D, Cass, CE, Young, JD, Said, J, Cheson, B & Hsi, ED 2008, 'High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/ refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - A CALGB 59804 correlative study', Leukemia and Lymphoma, vol. 49, no. 6, pp. 1202-1205. https://doi.org/10.1080/10428190802094237

High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/ refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - A CALGB 59804 correlative study. / Lai, Raymond; Bartlett, Nancy L.; Mackey, John R. et al.
In: Leukemia and Lymphoma, Vol. 49, No. 6, 06.2008, p. 1202-1205.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/ refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - A CALGB 59804 correlative study

AU - Lai, Raymond

AU - Bartlett, Nancy L.

AU - Mackey, John R.

AU - Jung, Sin Ho

AU - Johnson, Jeffrey L.

AU - Cook, James R.

AU - Jones, Dan

AU - Cass, Carol E.

AU - Young, James D.

AU - Said, Jonathan

AU - Cheson, Bruce

AU - Hsi, Eric D.

PY - 2008/6

Y1 - 2008/6

UR - http://www.scopus.com/inward/record.url?scp=46749094286&partnerID=8YFLogxK

U2 - 10.1080/10428190802094237

DO - 10.1080/10428190802094237

M3 - Letter

C2 - 18452103

AN - SCOPUS:46749094286

SN - 1042-8194

VL - 49

SP - 1202

EP - 1205

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 6

ER -

Lai R, Bartlett NL, Mackey JR, Jung SH, Johnson JL, Cook JR et al. High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/ refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - A CALGB 59804 correlative study. Leukemia and Lymphoma. 2008 Jun;49(6):1202-1205. doi: 10.1080/10428190802094237

High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/ refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - A CALGB 59804 correlative study

Access to Document

Other files and links

Cite this